Cetera Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Cetera Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,431	Closed	-$246K	–	2491
2023 Q4	$246K	Buy	+10,431	New	+$186K	﹤0.01%	1531

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cetera Advisors's CBAY Position: Q1 2024 in Review

Cetera Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 10,431 shares — an estimated $246K sold.

Cetera Advisors first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $246K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Cetera Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Cetera Advisors sold 10,431 Cymabay Therapeutics shares in Q1 2024, an estimated $246K.
Cetera Advisors first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Cetera Advisors's Cymabay Therapeutics position peaked at $246K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.